Quantitative Systematic Strategies LLC Nevro Corp Transaction History

Quantitative Systematic Strategies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$101.99 - $166.36 $835,502 - $1.36 Million	-8,192 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$141.6 - $179.06 $644,988 - $815,618	-4,555 Reduced 35.73%	8,192 $1.36 Million
Q1 2021 May 06, 2021	SELL	$132.81 - $182.18 $1.41 Million - $1.94 Million	-10,648 Reduced 45.51%	12,747 $1.78 Million
Q4 2020 Feb 09, 2021	BUY	$138.17 - $184.34 $515,097 - $687,219	3,728 Added 18.96%	23,395 $4.05 Million
Q3 2020 Nov 09, 2020	SELL	$114.09 - $145.51 $283,855 - $362,028	-2,488 Reduced 11.23%	19,667 $2.74 Million
Q2 2020 Aug 04, 2020	BUY	$89.45 - $129.85 $1.3 Million - $1.89 Million	14,528 Added 190.48%	22,155 $2.65 Million
Q1 2020 May 06, 2020	BUY	$70.23 - $144.31 $264,977 - $544,481	3,773 Added 97.9%	7,627 $763,000
Q4 2019 Feb 11, 2020	BUY	$76.41 - $117.54 $294,484 - $452,999	3,854 New	3,854 $451,000
Q3 2018 Nov 14, 2018	SELL	$44.22 - $75.47 $123,329 - $210,485	-2,789 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$72.38 - $92.5 $201,867 - $257,982	2,789 New	2,789 $223,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $116M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.